Therapeutic potential of dendritic cell-based immunization against HBV in transgenic mice

Antiviral Research

Volumn 77, Issue 1, 2008, Pages 50-55

  Jiang, Wen Zheng ^a   Fan, Yan ^a   Liu, Xia ^b   Zhang, Ya Li ^a   Wen, Jie Jun ^a   Hao, Wen Li ^a   Qian, Min ^a  

^a EAST CHINA NORMAL UNIVERSITY   (China)

^b SECOND MILITARY MEDICAL UNIVERSITY   (China)

Author keywords

Cytotoxic T lymphocyte; Dentritic cell; Epitope; Hepatitis B virus; Transgenic mice

Indexed keywords

ALANINE AMINOTRANSFERASE; ASPARTATE AMINOTRANSFERASE; DENDRITIC CELL VACCINE; GAMMA INTERFERON; VIRUS ANTIGEN; VIRUS DNA; VIRUS ENVELOPE PROTEIN;

ALANINE AMINOTRANSFERASE BLOOD LEVEL; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIGEN DETECTION; ARTICLE; ASPARTATE AMINOTRANSFERASE BLOOD LEVEL; BLOOD LEVEL; CD8+ T LYMPHOCYTE; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; CYTOTOXIC T LYMPHOCYTE; DENDRITIC CELL; DRUG POTENCY; DRUG PULSE THERAPY; ENZYME ACTIVITY; ENZYME LINKED IMMUNOSORBENT ASSAY; ENZYME LINKED IMMUNOSPOT ASSAY; FEMALE; HEPATITIS B; HEPATITIS B VIRUS; IMMUNIZATION; IMMUNOPHARMACOLOGY; IMMUNOSTIMULATION; MOUSE; NONHUMAN; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; SPLEEN CELL; T LYMPHOCYTE ACTIVATION; TRANSGENIC MOUSE; VIRUS ENVELOPE;

ANIMALS; CYTOTOXICITY, IMMUNOLOGIC; DENDRITIC CELLS; FEMALE; HEPATITIS B SURFACE ANTIGENS; HEPATITIS B VIRUS; HEPATITIS B, CHRONIC; IMMUNIZATION; IMMUNOTHERAPY; INTERFERON TYPE II; MICE; MICE, INBRED BALB C; MICE, TRANSGENIC; T-LYMPHOCYTES, CYTOTOXIC;

HEPATITIS B VIRUS; MUS; MUS MUSCULUS;

EID: 37449011962     PISSN: 01663542     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.antiviral.2007.08.004     Document Type: Article

References (33)

1. Akbar S.M., Furukawa S., Hasebe A., Horiike N., Michitaka K., and Onji M. Production and efficacy of a dendritic cell-based therapeutic vaccine for murine chronic hepatitis B virus carrier. Int. J. Mol. Med. 14 (2004) 295-299
2. Akbar S.M., Kajino K., Tanimoto K., Kurose K., Masumoto T., Michitaka K., Horiike N., and Onji M. Placebo-controlled trial of vaccination with hepatitis B virus surface antigen in hepatitis B virus transgenic mice. J. Hepatol. 26 (1997) 131-137
3. Arbuthnot P., and Kew M. Hepatitis B virus and hepatocellular carcinoma. Int. J. Exp. Pathol. 82 (2001) 77-100
4. Banchereau J., and Steinman R.M. Dendritic cells and the control of immunity. Nature 392 (1998) 245-252
5. Birrer R.B., Birrer D., and Klavins J.V. Hepatocellular carcinoma and hepatitis virus. Ann. Clin. Lab. Sci. 33 (2003) 39-54
6. Bloom B.S., Hillman A.L., Fendrick A.M., and Schwartz J.S. A reappraisal of hepatitis B virus vaccination strategies using cost-effectiveness analysis. Ann. Intern. Med. 118 (1993) 298-306
7. Chaiken I.M., and Williams W.V. Identifying structure-function relationships in four-helix bundle cytokines: towards de novo mimetics design. Trends Biotechnol. 14 (1996) 369-375
8. Chisari F.V. Hepatitis B virus transgenic mice: models of viral immunobiology and pathogenesis. Curr. Top. Microbiol. Immunol. 206 (1996) 149-173
9. Guermonprez P., Valladeau J., Zitvogel L., Théry C., and Amigorena S. Antigen presentation and T cell stimulation by dendritic cells. Annu. Rev. Immunol. 20 (2002) 621-667
10. Guidotti L.G., Ando K., Hobbs M.V., Ishikawa T., Runkel L., Schreiber R.D., and Chisari F.V. Cytotoxic T lymphocytes inhibit hepatitis B virus gene expression by a noncytolytic mechanism in transgenic mice. Proc. Natl. Acad. Sci. U.S.A. 91 (1994) 3764-3768
11. Guidotti L.G., Borrow P., Hobbs M.V., Matzke B., Gresser I., Oldstone M.B., and Chisari F.V. Viral cross talk: intracellular inactivation of the hepatitis B virus during an unrelated viral infection of the liver. Proc. Natl. Acad. Sci. U.S.A. 93 (1996) 4589-4594
12. Guidotti L.G., Ishikawa T., Hobbs M.V., Matzke B., Schreiber R., and Chisari F.V. Intracellular inactivation of the hepatitis B virus by cytotoxic T lymphocytes. Immunity 4 (1996) 25-36
13. Guidotti L.G., Matzke B., Schaller H., and Chisari F.V. High-level hepatitis B virus replication in transgenic mice. J. Virol. 69 (1995) 6158-6169
14. Guidotti L.G., Rochford R., Chung J., Shapiro M., Purcell R., and Chisari F.V. Viral clearance without destruction of infected cells during acute HBV infection. Science 284 (1999) 825-829
15. Hart D.N. Dendritic cells: unique leukocyte populations which control the primary immune response. Blood 90 (1997) 3245-3287
16. Inaba K., Inaba M., Romani N., Aya H., Deguchi M., Ikehara S., Muramatsu S., and Steinman R.M. Generation of large numbers of dendritic cells from mouse bone marrow cultures supplemented with granulocyte/macrophage colony-stimulating factor. J. Exp. Med. 176 (1992) 1693-1702
17. Inaba K., Metlay J.P., Crowley M.T., and Steinman R.M. Dendritic cells pulsed with protein antigens in vitro can prime antigen-specific, MHC-restricted T cells in situ. J. Exp. Med. 172 (1990) 631-640
18. Löhr H.F., Pingel S., Böcher W.O., Bernhard H., Herzog-Hauff S., Rose-John S., and Galle P.R. Reduced virus specific T helper cell induction by autologous dendritic cells in patients with chronic hepatitis B-restoration by exogenous interleukin-12. Clin. Exp. Immunol. 130 (2002) 107-114
19. Mancini M., Hadchouel M., Davis H.L., Whalen R.G., Tiollais P., and Michel M.L. DNA-mediated immunization in a transgenic mouse model of the hepatitis B surface antigen chronic carrier state. Proc. Natl. Acad. Sci. U.S.A. 93 (1996) 12496-12501
20. Moriyama T., Guilhot S., Klopchin K., Moss B., Pinkert C.A., Palmiter R.D., Brinster R.L., Kanagawa O., and Chisari F.V. Immunobiology and pathogenesis of hepatocellular injury in hepatitis B virus transgenic mice. Science 248 (1990) 361-364
21. Pol S., and Michel M.L. Therapeutic vaccination in chronic hepatitis B virus carriers. Expert Rev. Vaccines 5 (2006) 707-716
22. Roh S., and Kim K. Overcoming tolerance in hepatitis B virus transgenic mice: a possible involvement of regulatory T cells. Microbiol. Immunol. 47 (2003) 453-460
23. Schirmbeck R., Böhm W., Ando K., Chisari F.V., and Reimann J. Nucleic acid vaccination primes hepatitis B surface antigen-specific cytotoxic T lymphocytes in nonresponder mice. J. Virol. 69 (1995) 5929-5934
24. Sette A.D., Oseroff C., Sidney J., Alexander J., Chesnut R.W., Kakimi K., Guidotti L.G., and Chisari F.V. Overcoming T cell tolerance to the hepatitis B virus surface antigen in hepatitis B virus-transgenic mice. J. Immunol. 166 (2001) 1389-1397
25. Sheng K.C., Pietersz G.A., Wright M.D., and Apostolopoulos V. Dendritic cells: activation and maturation-applications for cancer immunotherapy. Curr. Med. Chem. 12 (2005) 1783-1800
26. Shimizu Y., Guidotti L.G., Fowler P., and Chisari F.V. Dendritic cell immunization breaks cytotoxic T lymphocyte tolerance in hepatitis B virus transgenic mice. J. Immunol. 161 (1998) 4520-4529
27. Sornasse T., Flamand V., De Becker G., Bazin H., Tielemans F., Thielemans K., Urbain J., Leo O., and Moser M. Antigen-pulsed dendritic cells can efficiently induce an antibody response in vivo. J. Exp. Med. 175 (1992) 15-21
28. Steinman R.M. The dendritic cell system and its role in immunogenicity. Annu. Rev. Immunol. 9 (1991) 271-296
29. Steinman R.M. Dendritic cells and immune-based therapies. Exp. Hematol. 24 (1996) 859-862
30. + T cells mediate viral clearance and disease pathogenesis during acute hepatitis B virus infection. J. Virol. 77 (2003) 68-76
31. Tsui L.V., Guidotti L.G., Ishikawa T., and Chisari F.V. Posttranscriptional clearance of hepatitis B virus RNA by cytotoxic T lymphocyte-activated hepatocytes. Proc. Natl. Acad. Sci. U.S.A. 92 (1995) 12398-12402
32. Wieland S.F., Guidotti L.G., and Chisari F.V. Intrahepatic induction of IFN-α/β eliminates viral RNA-containing capsids in hepatitis B virus transgenic mice. J. Virol. 74 (2000) 4165-4173
33. Wirth S., Guidotti L.G., Ando K., Schlicht H.J., and Chisari F.V. Breaking tolerance leads to autoantibody production but not autoimmune liver disease in HBV envelope transgenic mice. J. Immunol. 154 (1995) 2504-2515